Moneycontrol Presented by Motilal Oswal
Days hours minutes
Nerolac
Presented by :

Co-Presenting Sponsor :

Capital Trade

Powered by :

Godrej Properties

Associate Sponsors :

Aegon Life
LIC Housing Finance
Indiabulls
DHFL

Co-Presenting Sponsor

Capital Trade

Associate Sponsors

  • Indiabulls
  • Aegon Life
  • LIC Housing Finance
  • DHFL
SENSEX NIFTY
YOU ARE HERE >  Moneycontrol Markets > Announcements Pharmaceuticals

Lupin

BSE: 500257|NSE: LUPIN|ISIN: INE326A01037|SECTOR: Pharmaceuticals
SET ALERT
|
ADD TO PORTFOLIO
|
WATCHLIST
LIVE
BSE
Jan 19, 16:00
923.00
4.6 (0.5%)
VOLUME 173,721
LIVE
NSE
Jan 19, 15:59
924.10
3.05 (0.33%)
VOLUME 1,343,268
Announcements on Lupin

19th-Jan-2018 14:24Source: NSE

Lupin Limited

Lupin Limited has informed the Exchange regarding a press release dated January 19, 2018, titled "Lupin launches generic Vibra-Tabs® Tablet in the US".

19th-Jan-2018 13:38Source: BSE

Lupin- Press Release / Media Release

Lupin launches generic Vibra-Tabs Tablet in the US.

19th-Jan-2018 12:35Source: NSE

Lupin Limited

Lupin Limited has informed the Exchange regarding allotment of 29899 securities pursuant to ESOP/ESPS at its meeting held on January 19, 2018

19th-Jan-2018 11:24Source: BSE

Lupin- Allotment

Disclosure pursuant to the Regulation 30(2) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015 - Allotment of shares under ESOP
----------------------------...

15th-Jan-2018 14:33Source: NSE

Lupin Limited

Lupin Limited has informed the Exchange regarding a press release dated January 15, 2018, titled "Lupin forays into the OTC segment with Softovac".

15th-Jan-2018 13:41Source: BSE

Lupin- Press Release / Media Release

Lupin forays into the OTC segment with Softovac.

12th-Jan-2018 15:44Source: BSE

Lupin- Sub: Investor Grievances Report For The Quarter Ended 31.12.2017

In terms of Regulation 13 (3) of the SEBI (Listing obligations and Disclosure Requirements) Regulations, 2015, the statement of Investor Complaints for the quarter ended 31st December, 2017 is enclos...

10th-Jan-2018 15:58Source: BSE

Lupin- Press Release / Media Release

Lupin has received final USFDA approval for Oseltamivir Phosphate Capsules USP, 30 mg (base), 45 mg (base), and 75 mg (base) to market a generic version of Hoffman-La Roche, Inc.s Tamiflu Capsules, 3...

10th-Jan-2018 14:11Source: NSE

Lupin Limited

Lupin Limited has informed the Exchange regarding a press release dated January 10, 2018, titled "Lupin receives FDA approval for generic Tamiflu Capsules".

9th-Jan-2018 22:45Source: BSE

Lupin- Investor Presentation

J.P. Morgan Healthcare Conference.

1 2 3 4 5 Next >>
Quick Links for Lupin
Explore Moneycontrol
Stocks     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z | Others
Mutual Funds     A | B | C | D | E | F | G | H | I | J | K | L | M | N | O | P | Q | R | S | T | U | V | W | X | Y | Z
Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.